Filing Details

Accession Number:
0001209191-19-012808
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-22 21:34:59
Reporting Period:
2019-02-22
Accepted Time:
2019-02-22 21:34:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
897448 Amarin Corp Plc AMRN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331852 S Joseph Zakrzewski C/o Amarin Pharma, Inc.
1430 Route 206
Bedminster NJ 07921
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-02-22 143,750 $8.86 228,297 No 4 M Direct
Ordinary Shares Acquisiton 2019-02-22 36,875 $8.10 265,172 No 4 M Direct
Ordinary Shares Disposition 2019-02-22 180,625 $19.90 84,547 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-02-22 143,750 $0.00 143,750 $8.86
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-02-22 36,875 $0.00 36,875 $8.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-02-01 No 4 M Direct
0 2023-01-02 No 4 M Direct
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  3. The stock option granted to the Reporting Person is fully vested as of the date hereof.